Skip to content

APOTHEEK ROOSEVELT

Active
Private limited companyfounded 2011active for 15 yearsSint-Jacobsmarkt 98, 2000 Antwerpen, BelgiumKBO/BCE: BE 0839.539.255
Summary

APOTHEEK ROOSEVELT has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €29,689 and a net result of €17,488, of which €39,086 non-recurring income. Equity is shrinking by about 9% per year across the filed financial years. Its solvency ranks better than 20% of 12,661 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).

Risk analysisFollow ReportCompare
APOTHEEK ROOSEVELTActiveChecked score 66/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€318,502total assets 2025
Staff
2.3 FTE
Equity
€29,689
Profit
€17,488
Turnover not published (abbreviated format)
Financial health
66 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.8%
Structure
Parent
GALENUS APOTHEKEN · 100%
2025 accounts 32 days early2 of 5 deeds summarised
Why 66raises riskEquity €29,689 (9.3% of total assets)Sector: Retail trade (NACE 47)lowers riskFounded in 2011Show the evidence

Checked score

Score 2025
66 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 24% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Weak
Solvency 34+3
equity 9.3% of total assets
Liquidity 13-35
short-term debt 89.6% · cash 10.5%
Profitability 43-17
return on assets 5.5%
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%

About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,231 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1%lowest value 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.2%▲ +0.1 percentage points vs 02-2025 04-2025: 0.5%▲ +0.3 percentage points vs 03-2025 05-2025: 0.5%● unchanged vs 04-2025 06-2025: 0.5%● unchanged vs 05-2025 07-2025: 0.5%● unchanged vs 06-2025 08-2025: 0.5%● unchanged vs 07-2025 09-2025: 0.5%● unchanged vs 08-2025 10-2025: 0.5%● unchanged vs 09-2025 11-2025: 0.5%● unchanged vs 10-2025 12-2025: 0.5%● unchanged vs 11-2025 01-2026: 0.5%● unchanged vs 12-2025 02-2026: 0.5%● unchanged vs 01-2026 03-2026: 0.6%▲ +0.1 percentage points vs 02-2026 04-2026: 0.8%▲ +0.2 percentage points vs 03-2026 05-2026: 1.2%▲ +0.4 percentage points vs 04-2026 06-2026: 1.5%▲ +0.3 percentage points vs 05-2026highest value 07-2026: 0.8%▼ -0.7 percentage points vs 06-2026 08-2026: 0.8%● unchanged vs 07-2026 09-2026: 0.8%● unchanged vs 08-2026 10-2026: 0.8%● unchanged vs 09-2026
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.95, compared with 1.34 in 2024, below 1; short-term debt: 89.6% and cash: 10.5% of total assets), and 90.7% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 26% on solvency, 13% on liquidity and 32% on profitability.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Equity €29,689 (9.3% of total assets)
NBB · annual accounts
lowers risk · Founded in 2011
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 12661 sector peers (2025).
NBB · sector comparison
Position among 12661 sector peers
Solvency
better than 20%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
32 days early
2024
44 days early
2023
97 days early
2022
38 days early
2021
40 days early
2020
29 days early
2019
29 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 44 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Resignation: GALENUS APOTHEKEN BV (director)Permanent representatives: Bart Van Ghyseghem…
  3. Resignation: GALENUS APOTHEKEN (manager)Appointment: GALENUS APOTHEKEN (director) ·…

Key points

  • Caution: Among the weakest 20% on solvencysector median 36.7% · 12,661 companies 9.3% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Controlled by GALENUS APOTHEKEN 100% View
  • Positive: 7 profitable years in a rowprofit 2025: €17,488, mostly one-off 7 years View

By topic

Financials

Financial year
2025
Total assets
€318,502
Profit
€17,488
Solvency
9.3%
Total assets▼ 45.8%
Net result
20192025
Go to Financials

Timeline

Events
18
Since
2013
  1. 17-03-2025Annual accounts filed
  2. 24-01-2024Annual accounts filed
  3. 23-03-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
22-09-2011
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
14
Who signs
Each director alone
Purpose
“Het oprichten, huren, overnemen en uitbaten van apotheken: de aan en verkoop, de in- en…” (deed in Dutch)
Go to Articles of association

Key facts about APOTHEEK ROOSEVELT

What is the company number of APOTHEEK ROOSEVELT?
0839.539.255. In Belgium the VAT number is the company number with BE in front: BE 0839.539.255.
Where is APOTHEEK ROOSEVELT based?
The registered office is at Sint-Jacobsmarkt 98, 2000 Antwerpen.Company details
What does APOTHEEK ROOSEVELT do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK ROOSEVELT?
Private limited company (BV).
When was APOTHEEK ROOSEVELT founded?
On 22-09-2011.
Is APOTHEEK ROOSEVELT still active?
Yes, APOTHEEK ROOSEVELT is an active enterprise in the KBO register.
How many employees does APOTHEEK ROOSEVELT have?
On average 2.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK ROOSEVELT?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is APOTHEEK ROOSEVELT profitable?
In financial year 2025, APOTHEEK ROOSEVELT made a profit of €17,488.
Where can I find the annual accounts of APOTHEEK ROOSEVELT?
APOTHEEK ROOSEVELT filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.

Companies related to APOTHEEK ROOSEVELT

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure